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Abstract
Purpose: In this study, the potential of matrix metalloproteinase (MMP) sense for detection of
atherosclerotic plaque instability was explored. Secondly, expression of MMPs by macrophage
subtypes and smooth muscle cells (SMCs) was investigated.
Procedures: Twenty-three consecutive plaques removed during carotid endarterectomy were
incubated in MMPSense™ 680 and imaged with IVIS® Spectrum. mRNA levels of MMPs,
macrophage markers, and SMCs were determined in plaque specimens, and in in vitro
differentiated M1 and M2 macrophages.
Results: There was a significant difference between autofluorescence signals and MMPSense
signals, both on the intraluminal and extraluminal sides of plaques. MMP-9 and CD68
messenger RNA (mRNA) expression was higher in hot spots, whereas MMP-2 and αSMA
expression was higher in cold spots. In vitro M2 macrophages had higher mRNA expression of
MMP-1, MMP-9, MMP-12, and TIMP-1 compared to M1 macrophages.
Conclusion: MMP-9 is most dominantly MMP present in atherosclerotic plaques and is produced
by M2 rather than M1 macrophages.
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Introduction
Atherosclerosis is a progressive inflammatory disease
characterized by the accumulation of lipid-filled macro-
phages within the arterial intima. Continued inflammation
may promote rupture of the atherosclerotic plaque’s
protective fibrous cap causing subsequent clinical ische-
mic events [1, 2]. The fibrous cap covering an advanced
atherosclerotic plaque is typically composed of smooth
muscle cells (SMCs) and extracellular matrix (ECM) [3].
Activated monocyte-derived macrophages and SMCs are
critically involved in the development of high-risk
vulnerable plaques by producing matrix metalloprotei-
nases (MMPs) [1, 4, 5].
A heterogeneous population of macrophages exists
including a classically activated macrophage type (M1) as
well as an alternatively activated macrophage population
(M2) [6]. The M1 macrophage is thought to have pro-
inflammatory properties, and polarization in vitro is driven
by low concentration lipopolysacharride (LPS) and
interferon-gamma (IFN-γ). Defined as classically, however,
M2 macrophages are anti-inflammatory and immune regu-
latory. Upon cytokine stimulation, they modify development
of atherosclerotic plaques. The M2 macrophage population
can be divided in M2a, M2b, and M2c subtypes, depending
on the cytokine environment (IL-4, immune complexes, and
IL-10, respectively)[7]. In contrast to its classical M2
properties, the function of M2a macrophages is type II
inflammation, and the function of type M2c is matrix
deposition and tissue remodeling; this last mentioned type
might be most important in atherosclerosis [8]. Recently,
Wolfs et al. suggested that additional circumstances in the
local microenvironment makes macrophage polarization in
the atherosclerotic tissue even more complex than the
typically described M1 and M2 macrophage distribution
[9]. So, not only cytokine environment, but also foam cell
formation and chemokine ligand 4 (CXCL4), among other
factors, play major roles.
MMPs are proteolytic enzymes that can degrade ECM
proteins such as gelatin (MMP-2 and MMP-9), collagen
(MMP-1, MMP-8, and MMP-13), elastin (MMP-12), and
fibrin (MMP-3 and MMP-10). They can be inhibited by
tissue inhibitors of metalloproteinases (TIMPs). The ever-
growing MMP family now consists of more than 20 known
proteins [10]. There is conflicting evidence about the role of
MMP-9 in atherosclerosis. In carotid atherosclerotic disease,
MMP-9 is associated with the development of unstable
plaques. In patients with symptomatic carotid disease,
increased MMP-9 levels have been shown both in plasma
and in plaque tissue [11–16]. Other studies showed an
inverse relation between plaque activity and MMP-9
plasma levels or even evidence for a plaque-stabilizing
role for MMP-9 [17, 18]. At the moment, MMPs cannot
be visualized with conventional imaging modalities, such
as duplex ultrasound, computerized tomography scan-
ning, and magnetic resonance imaging. Although these
conventional imaging techniques have improved and do
have the ability to image cardiovascular anatomy and
physiology on a macroscopic scale, they lack the
possibility to detect biological processes at the cellular
or molecular level [19]. In contrast, molecular imaging
has the possibility to target molecular components of
atherosclerotic disease on a microscopic scale using
smart activatable probes [20]. As such, MMPs may be
targeted with a MMP-sensitive probe (MMPSense) and
can be visualized by fluorescence imaging [21–23].
MMPSense is a protease activatable fluorescent imaging
agent that is activated by MMP-2, MMP-3, MMP-9, and
MMP-13. MMPSense is optically silent in its inactivated
state and becomes highly fluorescent following protease-
mediated activation. Previously, we showed that
MMPSense detected most likely MMP-9 in hot spots,
which are in regions with high uptake [23]. Also,
increased presence of CD68-positive macrophages was
present in these hot spots.
In this study, we analyzed the presence of MMPs in
human carotid plaques by using MMPSense and investigated
differences in intensity of fluorescence signals. Furthermore,
monocytes were in vitro differentiated and polarized into
M1, M2a, and M2c macrophages to investigate expression
of MMPs in these subtypes, as well as in SMCs. In this way,
the potential of MMPSense as marker for atherosclerotic
carotid plaque vulnerability was explored, and the relation to
MMP expression of macrophage subtypes and SMCs
throughout atherosclerotic plaques.
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Materials and Methods
Study Design
Patients presenting with symptoms (i.e., with a history of recent
cerebrovascular accident (CVA)), transient ischemic attack (TIA or
amaurosis fugax), and a stenosis of the common carotid artery of
70–99 % as detected by duplex ultrasound examination underwent
open carotid surgery at the University Medical Center Groningen
(UMCG). Additionally, asymptomatic patients (mean age 71 years,
range 51–81 years) with a stenosis of 80–99 %, found by routine
control were also eligible for surgical treatment. Therefore, a total
of 23 carotid specimens were obtained by means of carotid
endarterectomy (CEA) of the carotid bifurcation using standard
techniques [24]. Risk factors such as hyperlipidemia, hypertension,
smoking status, obesity (body mass index (BMI)), and diabetes
mellitus were recorded. Hyperlipidemia and hypertension were
defined as described before by our group [25]. To measure MMP
expression in differentiated macrophages, ten healthy volunteers
were included without known cardiovascular disease or risk factors.
The study was approved by the Institutional Review Board (IRB) of
the UMCG, and informed consent was obtained from all individual
participants included in the study.
Carotid Endarterectomy Sample Collection and
Timepath of Study
Plaques were obtained immediately after endarterectomy. Follow-
ing endarterectomy, all specimens were washed with PBS to
remove blood and debris. After storage in PBS, samples were put
on ice and taken to the laboratory for fluorescence imaging. The
plaques were cut open longitudinally and pinched on a silicone
plate with nonreflective black paper (XPB-24 black paper, Caliper
Life Sciences, Hopkinton, MA, USA) in between to reduce
autofluorescence. Then, autofluorescence signals were recorded
on the intraluminal and extraluminal sides of the plaque. The mean
time between excision of the plaque and determination of
autofluorescence was 31 min (16–45). It took 9 min (2–26) to
complete the autofluorescence recordings. After that, the plaque
was incubated with a MMP-sensitive activatable fluorescent probe
(MMPSense™680, VisEn Medical, Boston, MA, USA), which was
diluted 1:10. Specimens were incubated for 66 min (60–72) before
imaging.
Fluorescence Imaging and Data Analysis
Fluorescence images were obtained with a commercial imaging
system with an ultra-sensitive charge-coupled device camera
mounted on a light-tight black chamber (IVIS® spectrum, Caliper
Life Sciences, Hopkinton, MA, USA). The charged-coupled device
(CCD) camera was cooled to −90 °C. The excitation and emission
filter were set at Cy5.5. By dividing the mean radiance (p/s/cm2/sr)
from the MMPSense signal by the autofluorescence signal, the
target to background ratio (TBR) was calculated. The imaging data
were analyzed using Living Image® 3.0 software (Caliper Life
Sciences, Hopkinton, MA, USA).
Immunohistochemistry
Slices of plaques were embedded in paraffin, and sections of 4 μm
were cut. Macrophages were identified by incubation with
monoclonal mouse anti-human CD68 (1:50; mo876 clone PG-M1
DAKO, Glostrup, Denmark). For detection of MMP-9, a goat anti-
human antibody (AB911, R&D systems, Minneapolis, USA) was
used. Appropriate secondary antibodies labeled with horseradish
peroxidase (HRP) were used. Color reaction was developed using
DAB staining with chromogen, and sections were counterstained
with hematoxylin.
In Vitro Differentiation and Polarization of M1,
M2a, and M2c Macrophages
From ten healthy donors peripheral blood mononuclear cells
(PBMCs) were isolated by density gradient centrifugation using
Lymphoprep (Axis Shield PoC As, Oslo, Norway). Subse-
quently, monocytes were allowed to adhere to culture plates.
The adherent cells were maintained for 5 days in RPMI 1640
medium (Lonza, Walkersville, MD, USA) supplemented with
10 % filtered fetal calf serum (FCS) and 20 ng/ml macrophage
colony-stimulating factor (M-CSF, R&D Systems) for differen-
tiation into macrophages. Macrophages were directed toward
M1, M2a, and M2c phenotypes by use of 48-h stimulation with
100 U/ml IFN-γ (PeproTech, USA) and 1 ng/ml LPS (Sigma,
Germany) (leading to M1), 20 ng/ml IL-4 (M2a), or 10 ng/ml
IL-10 (M2c) (PeproTech) or both IL-4 and IL-10 (IL-4/IL-10),
respectively. Validation of M1 and M2 marker expression after
differentiation was shown previously [26]. In that paper, we
showed that in vitro differentiated M1 macrophages have a
higher messenger RNA (mRNA) expression of pro-
inflammatory TNF-α and TLR-2 compared to M2 macrophages
(IL-4/IL-10), who in turn have higher mannose receptor and
IL-10 mRNA expression. On receptor level, M1 showed to
have higher CD86 expression, while M2 macrophages have a
higher CD163 expression. By this method of differentiation
indeed M1 and M2 markers are expressed on these macro-
phages. MMP-9 protein was measured in supernatants of
cultured macrophages with ELISA (duoset, R&D Systems)
according to manufacturer’s description.
RNA Expression In Vitro in Macrophage Subtypes
and SMCs and Ex Vivo in Plaques
To measure MMP expression, RNA was extracted from above-
named macrophage subtypes and from SMCs as described
before [25]. From four imaged plaques, areas with high
intensity (hot spots) and low intensity (cold spots) were excised
and mRNA was isolated from these specimens. Four un-imaged
plaques were divided in equal slices of 5 mm, and mRNA was
also isolated from these slices. Complementary DNA (cDNA)
samples were added in duplicate for amplification by the
TaqMan real-time PCR system (ABI Prism 7900HT Sequence
Detection system, Applied Biosystems, Foster City, CA, USA).
mRNA expression of MMP-1, MMP-2, MMP-3, MMP-8,
MMP-9, MMP-12, MMP-13, MMP-14, –MMP-16, and TIMP-
1 was measured by using TaqMan primer/probes sets. The
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TaqMan primer/probe sets were the following: GAPDH:
Hs9999905_m1; MMP1: Hs00233958_m1; MMP2:
Hs01548727_m1; MMP3: Hs00233962_m1; MMP8:
Hs01029057_m1 ; MMP9: 00234579_m1 ; MMP12 :
Hs00899662_m1; MMP13: Hs00233992_m1; MMP14:
Hs01037009_m1; MMP16: Hs00234676_m1; and TIMP-1:
Hs00171558_m1. In slices of plaques, also mRNA expression
of CD68 (pan macrophages), CD86 (M1 macrophage marker),
CD163 (M2 macrophage marker), and αSMA (ACTA2) was
investigated. Threshold cycle (Ct) values were determined using
the software program SDS 2.4 (Applied Biosystems). Relative
gene expression was normalized to the expression of
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) and cal-
culated by the following formula: relative gene expression=
2–ΔCt (ΔCt=Ct gene of interest−Ct GAPDH).
Statistical Analysis
Values are presented as mean±standard deviation or median
(range), unless stated otherwise. For correlations, Pearson’s and
Spearman’s correlation coefficients were used when appropriate. A
two-tailed, paired Student’s t test was used for parametric
distributions (i.e., fluorescence signal and TBR). Nonpaired
continuous variables with a nonparametric distribution were
analyzed using the Mann-Whitney U test or with a Wilcoxon test
in case of paired samples. For comparing more than two
independent samples, the Kruskal-Wallis test (ANOVA) was used
(i.e., four types of macrophages). A two-sided p value G0.05 was
considered statistically significant. Statistical tests were done with
the Statistical Package for the Social Sciences (SPSS statistics
version 20.0, SPSS Inc.®, Chicago, IL, USA).
Results
Patient Demographics
A total of 15 men and eight women with a mean age of 70±
9 years were included. Baseline characteristics of partic-
ipants are shown in Table 1.
Fluorescence Imaging
Fluorescence signal of each plaque was recorded before
and after incubation with MMPSense™680. MMP signals
were heterogeneously distributed throughout plaques
(Fig. 1). The mean TBR was considered appropriate
and did not significantly differ between intraluminal and
extraluminal sides (7.15 vs 6.43; p=0.53). Fluorescence
signals clearly augmented after incubation with
MMPSense compared to autofluorescence, showing high-
ly significant differences on both intraluminal (mean
value 6.34 vs 1.09; pG0.0001) and extraluminal sides
(mean value 6.12 vs 1.04; pG0.0001) (Fig. 2).
Ex Vivo MMP, αSMA, and Macrophage
Expression in Plaques
MMP-2, MMP-9, αSMA, and CD68 mRNA expression
was investigated in hot and cold spots from 4 imaged
plaques. As can be seen in Fig. 3a, MMP-9 and CD68
expression was up regulated in hot spots, whereas MMP-
2 and αSMA were downregulated in hot spots. To
investigate the expression and distribution of MMPs,
and their relation to M1 and M2 macrophages in
plaques, slices of unimaged plaques (with intact mRNA)
were used for mRNA isolation. Expression of MMPs
was compared to CD68 (pan macrophages), and to an
M1 marker (CD86) and M2 macrophage marker
(CD163). Also, MMP expression was compared to
αSMA expression. The strongest correlation was found
between MMP-9 and CD68 mRNA expression (ρ=0.792,
pG0.001, Fig. 3b). Furthermore, MMP-9 expression was
100 to 1000 times higher compared to mRNA expression
of other MMPs (Fig. 3c). None of the other MMPs
showed a significant correlation with M1 and M2
macrophage markers, except for MMP-2 and MMP-14
which both correlated significantly with CD86 and
CD163. There was a significant correlation between
MMP-2 and αSMA expression (ρ=0.534, p=0.0027,
Fig. 3b). Immunohistochemical staining of plaques for
CD68 and MMP-9 showed overlap of CD68 and MMP-9
as can be seen in a representative picture in Fig. 3d.
MMP Expression in Macrophage Subtypes
and SMCs In Vitro
mRNA levels of GAPDH (household gene), MMP-1, MMP-
2, MMP-3, MMP-8, MMP-9, MMP-12, MMP-13, MMP-14,
MMP-16, and TIMP-1 were determined in M1, M2a, M2c,
and IL-4/IL-10-differentiated M2 macrophages from ten
healthy volunteers. mRNA expression of MMP-1 was
significantly increased in all three M2 macrophage types
compared to M1 macrophages (p=0.0395 (Kruskall-Wallis
(KW)), Fig. 4a). TIMP-1 expression was significantly
decreased in M1 macrophages compared to all M2 macro-
phages (p=0.0002 (KW), Fig. 4b). MMP-9 and MMP-12
mRNA was undetectable in SMCs. MMP-9 expression was
higher but not significantly increased in M2 macrophages
compared to M1 (ns, KW; Fig. 4c). However, the difference
between M1 and M2a or M2c macrophages was statistically
significant (Wilcoxon paired t test, pG0.05, Fig. 3c). MMP-
12 was significantly higher expressed in M2 macrophages
compared to M1 macrophages (p=0.0004 (KW), Fig. 4d).
On the contrary,MMP-2 andMMP-14 were significantly higher
in M1 macrophages compared to all types of M2 macrophages
(p=0.0047, p=0.0165, respectively (KW), Fig. 5). Of note,
MMP-1 and MMP-2 expression was high in SMCs. MMP-3,
MMP-8, MMP-13, and MMP-16 were undetectable in in vitro
generated macrophages and in SMCs. From mRNA data in
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plaques, it was shown that expression of MMP-9 was 100 to
1000 times higher compared to mRNA expression of other
MMPs (Fig. 3c). Therefore MMP-9 protein secretion was
investigated in supernatants of cultured macrophages. As
can be seen in Fig. 6, all different types of macrophages can
produce MMP-9 although M2 macrophages produce more
than M1 (ns when tested with KW test, p=0.029, paired t test
for M1 against M2c). So protein levels of MMP-9 are
comparable to the mRNA expression of MMP-9 in different
subtypes of macrophages.
Discussion
Our study shows that fluorescence imaging with a smart
MMP-sensitive activatable probe clearly reveals a heteroge-
neous distribution of MMPs across the atherosclerotic
carotid plaques. The signals of ex vivo human carotid
plaques were significantly enhanced after incubation with
the fluorescent probe accounting for a 6- to 7-fold increase
of signals. MMP-9 mRNA was found to be highly expressed
in plaques and in different subtypes of M2 macrophages.
Signal enhancements such as with MMPSense have been
described using other protease probes, both in ex vivo
carotid specimens [22], and in vivo rabbits [27]. Typically,
there are more intense signals (hot spots) near the carotid
bifurcation. In a previous study, segments at or near the
bifurcation and segments with intraplaque hemorrhage
contained higher MMP levels and activity (especially
MMP-9) compared to segments distant from the bifurcation.
Histologically stable plaques contained lesser amounts of
MMPs, which were predominantly MMP-2. TIMPs were
highly abundant in fibrotic and necrotic segments [28]. In
the present study, it was shown that using MMPSense in
atherosclerotic plaques, mRNA expression of MMP-9 was
found to be increased in areas with high intensity (hot spots)
compared to areas with low intensity (cold spots) and
accompanied with a slight increase in CD68 mRNA
expression, as was previously found by Wallis-de Vries
et al. [23]. In the latter study, also increased enzymatic
gelatinase activity was shown in hot spots, and this was
appointed to increased presence of active MMP-9. mRNA
expression of MMP-2 was decreased in hot spots compared
to cold spots, and also αSMA expression. Also, good
correlations in plaques between mRNA expression of
Table 1. Baseline characteristics and risk factors for atherosclerosis
Patients (n=23)
Men, n (%) 15 (65)
Age (years) 70±9
Symptomatic, n (%) 21 (91)
Transient ischemic attack (TIA), n (%) 9 (39)
Cerebro vascular accident (CVA), n (%) 8 (35)
Amaurosis fugax, n (%) 4 (17)
BMI (kg/m2) 27±3
Smoking status, n (%) 10 (43)
91 pack a day, n (%) 6 (26)
≤1 pack a day, n (%) 4 (17)
None, smoked in last 10 years (%) 6 (26)
Hypertension, n (%) 19 (83)
Controlled with single drug, n (%) 5 (21)
Controlled with two drugs, n (%) 5 (21)
Requires 92 drugs or uncontrolled, n (%) 9 (39)
Systolic blood pressure (mmHg) 146±22
Diastolic blood pressure (mmHg) 80±12
Hyperlipidemia, n (%) 14 (61)
Use of lipid-lowering drugs, n (%) 9 (39)
Diabetes mellitus, n (%) 7 (30)a
aFour patients had diabetes controlled by diet or oral agents; three patients
were on insulin. Data are expressed as mean±standard deviation;
percentages are between brackets
Fig. 1. Ex vivo fluorescence imaging of human atherosclerotic plaques. Fluorescence signals reflecting MMPSense activation
in specific areas of plaque intraluminally (upper) and extraluminally (bottom): incubation in phosphate-buffered saline (left),
autofluorescence (middle), and incubation with MMPSense.
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MMP-9 and CD68, and between MMP-2 and SMCs were
found. These data are supported by another study, where
macrophage-rich lesions showed higher MMP-9 activity
while SMC-rich lesions showed higher MMP-2 activity [29].
Also, SMCs were found in stable plaques in other studies
[29, 30]. However, in an animal study using the mouse
brachiocephalic artery model of plaque instability, apolipo-
proteinE (apoE) knockout mice were crossed with MMP-3,
MMP-7, MMP-9, or MMP-12 knockouts [18]. Johnson et al.
found that in the apoE/MMP-3 and apoE/MMP-9 double
knockouts brachiocephalic artery plaques were significantly
larger than in controls and had reduced macrophage content.
They concluded that MMP-3 and MMP-9 normally played
protective roles, promoting stable plaques. It is unclear to
what extent this animal model can be compared to the
human situation.
In the present study, MMP-9 mRNA is abundantly
present in plaques and highly expressed by macrophages.
In a study by Loftus et al., the character, level, and
expression of MMPs in carotid plaques was correlated to
clinical status of patients undergoing carotid endarterec-
tomy. The MMP-9 concentration was significantly higher
in patients developing symptoms within 1 month com-
pared to asymptomatic patients [11]. Also, in a study
done by Heo et al., plaque rupture was significantly
associated with the development of vascular events in
Fig. 2. Intensity of fluorescence signals after incubation with MMPSense compared to autofluorescence. Fluorescence signals
of plaques incubated with MMPSense (MMP) were increased both a intraluminally and b extraluminally when compared with
autofluorescence (AF). Intraluminal (IL) side (mean value 6.34×109 vs 1.09×109; pG0.0001) and extraluminal (EL) side (mean
value 6.12×109 vs 1.04×109; pG0.0001).
Fig. 3. Expression of MMPs in atherosclerotic plaques. Quantitative reverse transcriptase polymerase chain reaction (qRT-
PCR) was used to determine relative mRNA expression of different genes in human atherosclerotic plaques. a Areas with high
intensity (hot spots) and low intensity (cold spots) determined after incubation with MMPSense were excised from four imaged
plaques and subjected to RNA isolation and qRT-PCR. mRNA of MMP-2, MMP-9, CD68, and αSMA, expressed as fold change
in hot spots versus cold spots, was determined. b Relative mRNA expression of MMP-2, MMP-9, αSMA, and CD68 was
determined in slices from four unimaged plaques with qRT-PCR. MMP-9 and CD68 mRNA expression was significantly
correlated and also MMP-2 and αSMA mRNA expression (Spearman’s correlation). c Relative expression levels of different
MMPs were determined with qRT-PCR in slices from four unimaged plaques. d Immunohistochemical staining of CD68 (middle
panel) and MMP9 (right panel) in a plaque specimen (left panel).
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carotid atherosclerotic disease and with immunohisto-
chemical expression of MMP-2 and MMP-9 [31]. One
explanation for this might be that MMP-2 and MMP-9
are capable of degrading collagen type IV which is the
major component of the basement membrane [14]. No
difference in the levels of MMP-1, MMP-2, or MMP-3
was found between symptomatic and asymptomatic
patients [11]. It was also anticipated that serum levels
of MMP-9 and MMP-2 were significantly higher in
symptomatic patients compared to patients without
symptoms [12, 13]. However, another group found serum
MMPs where not predictive of local events, in a group
of 18 patients [32]. In the present in vitro study, mRNA
expression of MMP-2 was highest in pro-inflammatory
M1 macrophages and in SMCs. MMP-9 and MMP-12
mRNA was highest in M2 macrophages and could not be
found in SMCs. This was supported by other groups
who found an overexpression of MMP-9 in M2 macro-
phages [33], and differentiation toward M2 macrophages
upregulated MMP-12 expression [4]. However, Newby
et al. also suggest that each macrophage subtype (not
only M2) can be acted on by pro-inflammatory mediators
Fig. 4. Relative expression of MMP mRNA levels in macrophages from ten healthy volunteers and in SMCs. M1- and M2-
polarized macrophages were cultured from monocytes from ten healthy volunteers and subjected to RNA isolation and qRT-
PCR. Significantly higher relative expression in M2-like macrophages (gray bars) compared to M1-like macrophages (open bars)
was measured for a MMP-1, b TIMP-1, and d MMP-12. c MMP-9 was also higher. Relative expression of MMP-1 and TIMP-1
in SMCs is added in panels a and b, expression of MMP-9 and MMP-12 was undetectable in SMCs. Significant differences
(Wilcoxon paired t test) of M2 subtype compared to M1 macrophages is shown in figure: *pG0.05, **pG0.01.
Fig. 5. Relative expression of MMP mRNA levels in macrophages from ten healthy volunteers and in SMCs. M1- and M2-
polarized macrophages were cultured from monocytes from ten healthy volunteers and subjected to RNA isolation and qRT-
PCR. Significantly lower relative expression in M2 macrophages (gray bars) compared to M1-like macrophages (open bars) was
measured for a MMP-2 and b MMP-14. Significant differences (Wilcoxon paired t test) of M2 subtype compared to M1
macrophages is shown in figure: *pG0.05, **pG0.01.
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leading to activated states [4]. Further research is needed
to fully understand the mechanism of MMPs produced
by macrophages in the process of an atherosclerotic
plaque becoming vulnerable. Applications for noninva-
sive optical imaging of fluorescent signals could be of
less clinical value in coronary atherosclerosis because of
the limited penetration depth of only a few millimeters.
Therefore, we started testing a radiolabeled MMP tracer
in ex vivo atherosclerotic plaques recently, from which
the results look promising.
We found MMP-9 mRNA and protein expression was
100 to 1000 times higher compared to other MMPs.
Taken everything into account, it seems that MMPsense
can be used to detect areas of plaque instability primarily
by detection of MMP-9 produced by M2 macrophages.
Conclusion
It is feasible to image MMP-9 in atherosclerotic tissue
ex vivo using a smart activatable fluorescence probe and
fluorescence imaging. MMP-9 is produced by macro-
phages and is abundantly present in plaques as shown by
immunohistochemical staining and qRT-PCR. Further-
more, areas with high intensity (hot spots) have a higher
mRNA expression of MMP-9 compared to areas with
low intensity (cold spots). Also, MMP-9 expression was
highest in M2 macrophages and could not be found in
SMCs. In conclusion, MMPSense can be used to detect
MMP-9 in plaques and might therefore be a good marker
to investigate plaque instability.
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